Key result
Management of hypertension in the elderly requires consideration of specific pathophysiology, as there is scant and discordant data regarding the benefits of treatment in the very old.
While treating hypertension is beneficial up to age 80, management in the very old requires consideration of specific pathophysiology due to scant and discordant evidence.
Hypertension affects 30–50' of older people. It is an important reversible risk factor for cardiovascular morbidity and mortality. Multiple large intervention trials have established the efficacy of treating hypertension in people up to the age of 80. However, there is scant and discordant data regarding the benefits of treating hypertension in the very old. Hypertension in the elderly is characterised by specific pathophysiology that must be taken into account when devising a management plan.
No takes yet. Share an insight, caveat, or question.
Harvey et al. (2001) conducted a review in Hypertension. Hypertension management was evaluated. Management of hypertension in the elderly requires consideration of specific pathophysiology, as there is scant and discordant data regarding the benefits of treatment in the very old.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: